Additional Paid-In Capital
ResMed Additional Paid-In Capital increased by 1.5% to $2.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.2%, from $1.99B to $2.13B. Over 4 years (FY 2021 to FY 2025), Additional Paid-In Capital shows an upward trend with a 5.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A consistent increase is common for growth companies that frequently issue stock-based compensation or raise capital through equity markets.
Detailed definition
This represents the excess amount paid by investors for common shares above their stated par value. It is a critical com...
Peer comparison
This is a standard equity account for all publicly traded corporations, representing the cumulative historical premium paid by investors.
equity_additional_paid_in_capital_common_stockHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.62B | $1.64B | $1.63B | $1.65B | $1.68B | $1.70B | $1.71B | $1.73B | $1.77B | $1.79B | $1.82B | $1.85B | $1.90B | $1.92B | $1.96B | $1.99B | $2.03B | $2.06B | $2.10B | $2.13B |
| QoQ Change | — | +1.3% | -0.9% | +1.0% | +2.2% | +1.2% | +0.5% | +1.1% | +2.5% | +1.1% | +1.8% | +1.4% | +2.6% | +1.5% | +1.7% | +1.7% | +2.2% | +1.4% | +2.0% | +1.5% |
| YoY Change | — | — | — | — | +3.7% | +3.5% | +5.0% | +5.1% | +5.3% | +5.3% | +6.6% | +6.9% | +7.0% | +7.4% | +7.4% | +7.7% | +7.2% | +7.2% | +7.4% | +7.2% |
Additional Paid-In Capital at Other Companies
Frequently Asked Questions
- What is ResMed's additional paid-in capital?
- ResMed (RMD) reported additional paid-in capital of $2.13B in Q1 2026.
- How has ResMed's additional paid-in capital changed year-over-year?
- ResMed's additional paid-in capital increased by 7.2% year-over-year, from $1.99B to $2.13B.
- What is the long-term trend for ResMed's additional paid-in capital?
- Over 4 years (2021 to 2025), ResMed's additional paid-in capital has grown at a 5.8% compound annual growth rate (CAGR), from $1.62B to $2.03B.
- What does additional paid-in capital mean?
- The total amount of capital received from shareholders in excess of the nominal par value of the stock.